Clinical Trials
9 trialsNCT01135329 2026-05-27
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT05116917 2024-05-28
INFLUENCE
Herlev Hospital
Phase 2 Terminated
NCT05069935 2023-09-21
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Fate Therapeutics
Phase 1 Terminated
NCT05395052 2023-09-21
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Fate Therapeutics
Phase 1 Terminated
NCT01561989 2020-03-10
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Roswell Park Cancer Institute
Phase NA Terminated
NCT01924169 2018-09-20
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01695733 2018-08-31
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT01215981 2017-12-28
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00596336 2017-04-12
CLLIFVAC
The Royal Bournemouth Hospital
Phase 2 Terminated